×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche...
5 days ago
BioVaxys snatches up 'bankrupt' IMV's preclinical and clinical assets
Pharmaceutical Technology
BioVaxys will pay $750,000 in upfront payments, along with milestone-based payments and royalties on licensing revenue and product sales.
3 months ago
BioVaxys Secures Funding for Immunotherapy Advancement - TipRanks.com
Tipranks
Biovaxys Technology Corp (TSE:BIOV) has released an update. BioVaxys Technology Corp. has successfully completed the second tranche of its non-brokered...
5 days ago
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT
The Globe and Mail
Detailed price information for Biovaxys Technology Corp (BVAXF) from The Globe and Mail including charting and trades.
3 days ago
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the ...
Canada Newswire
Through the transaction, BioVaxys has acquired 25 distinct families of patents and/or patent applications, with over one hundred related...
3 months ago
BioVaxys Acquires IP, Immunotherapeutics Platform Technology & Assets of IMV Inc.
Contract Pharma
BioVaxys Acquires IP, Immunotherapeutics Platform Technology & Assets of IMV Inc. Anticipates tremendous commercial potential with the DPX...
3 months ago
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
Sharecast.com
VANCOUVER, BC, May 2, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this...
2 weeks ago
The Globe and Mail
The Globe and Mail
THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES //. VANCOUVER, BC, May 10, 2024 /CNW/ -- BioVaxys...
5 days ago
BioVaxys Secures Funding for Immunotherapy Growth - TipRanks.com
Tipranks
Biovaxys Technology Corp (TSE:BIOV) has released an update. BioVaxys Technology Corp. has successfully completed the first tranche of its...
2 weeks ago
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS ...
PR Newswire
PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has...
2 months ago